2 results
Approved WMOCompleted
To assess indacaterol (300 and 600 ug once daily via SDDPI) superiority in patients with COPD as compared to placebo with respect to 24 h post dose (through) FEV1 after 12 weeks of treatment.
Approved WMOCompleted
Main: To evaluate the safety and effectiveness of the Exhale Drug-Eluting Stent (DES) to improve pulmonary function for homogeneous emphysema subjects with severe hyperinflation, in a prospective, randomized, Sham-controlled, double-blind, multi-…